Our results revealed HSPD1 as a ubiquitous lung cancer dependency gene, which maintains the metabolic fitness and promotes growth/survival, thus highlighting it as an attractive therapeutic target for NSCLC. Here, HSPD1 is linked to lung carcinoma.